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Immediate-early protein ICP0 of herpes simplex virus type 1 (HSV-1) is important for the
regulation of lytic and latent viral infection. Like the related proteins expressed by other
alphaherpesviruses, ICP0 has a zinc-stabilized RING finger domain that confers E3 ubiquitin
ligase activity. This domain is essential for the core functions of ICP0 and its activity leads to the
degradation of a number of cellular proteins, some of which are involved in cellular defences that
restrict viral infection. The article reviews recent advances in ICP0-related research, with an
emphasis on the mechanisms by which ICP0 and related proteins counteract antiviral restriction
and the roles in this process of cellular nuclear substructures known as ND10 or PML nuclear
bodies. We also summarize recent advances in the understanding of the biochemical aspects of
ICP0 activity. These studies highlight the importance of the SUMO conjugation pathway in both
intrinsic resistance to HSV-1 infection and in substrate targeting by ICP0. The topics discussed in
this review are relevant not only to HSV-1 infection, but also to cellular intrinsic resistance against
herpesviruses more generally and the mechanisms by which viruses can evade this restriction.
Introduction
After a primary infection, herpesviruses establish life-long
latent infections that periodically reactivate to enable
transmission between individuals and ensure viral main-
tenance within the host population (Knipe et al., 2006).
This review describes recent developments in studies on
ICP0, a herpes simplex virus type 1 (HSV-1) protein that
regulates both lytic and latent infection, and which
mediates its roles by influencing several cellular pathways
and proteins. All alphaherpesviruses that infect mam-
malian species express a member of the ICP0 family of
proteins, which is defined by the presence of domain,
known as a RING finger, that coordinates two zinc atoms
by conserved cysteine and histidine residues (Fig. 1; Barlow
et al., 1994). This domain confers E3 ubiquitin ligase
activity to ICP0 and its viral orthologues (Boutell et al.,
2002; Everett et al., 2010; Hagglund et al., 2002), mediating
the ubiquitination and proteasome-dependent degradation
of several cellular proteins during infection (Table 1).
There is abundant evidence that ICP0-related proteins play
central roles in alphaherpesvirus biology (Everett, 2006,
2011; Hagglund & Roizman, 2004; Smith et al., 2011). This
article discusses recent advances in this complex and at
times controversial subject area.
A brief summary of ICP0 biology during lytic
infection
ICP0 is a 775-residue protein that is required for efficient
lytic infection and productive reactivation from latency.
The phenotype of ICP0-null HSV-1 mutants is most easily
envisaged as a defect in the probability that a viral genome
will commit a cell to lytic infection. Therefore, compared
with wild-type (wt) virus, an ICP0-null mutant has a very
high particle to p.f.u. ratio. The extent of this defect is cell-
type dependent, being highest in human diploid fibroblasts
(around 1000-fold), intermediate in many commonly used
cell types (e.g. BHK, HeLa and Vero cells; 30–100-fold), and
absent in certain cell lines (e.g. U2OS cells) (Everett et al.,
2004; Yao & Schaffer, 1995). The defect is multiplicity
dependent, so that even restrictive cell types can be infected
efficiently if the amount of input virus is sufficiently high.
These issues complicate the design and interpretation of
experiments using ICP0 mutant viruses, as the results can be
highly influenced by both cell type and input multiplicity.
Experiments which measure consequences to the virus, such
as the probability of commitment to lytic infection or viral
gene expression, are best done at low multiplicity, based on
titres in U2OS cells. Experiments that investigate con-
sequences to the cell should be done at high multiplicity to
ensure that all the cells are actively infected. This concept is
based on the distinction between the direct effects of ICP0
itself, and the indirect effects resulting from a failure to
commit to lytic infection and therefore defects in the
expression of other viral proteins.
In low multiplicity infections of restrictive cell types the
ICP0-null mutant genomes that fail to initiate a lytic
infection are repressed and maintained in a quiescent state.
These quiescent genomes can be de-repressed by subsequent
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expression of ICP0 (reviewed by Efstathiou & Preston,
2005). Studies using animal models have indicated that
ICP0-null mutant HSV-1 can establish and maintain latency,
but reactivation in terms of the production of progeny virus
particles is compromised (reviewed by Efstathiou & Preston,
2005; Nicoll et al., 2012). It might be expected that expression
of ICP0 could be inimical to the establishment of latency by
wt HSV-1, but there is good evidence that at least some
transcription of the ICP0 gene has occurred in latently
infected mouse neurones (Proenc¸a et al., 2008, 2011). The
extent of ICP0 protein expression in this situation is
unknown at present, and it is possible that any ICP0 that is
expressed has reduced functionality (Chen et al., 2000). In
the context of individual neurones, reactivation of limited
viral gene expression can be detected in the absence of
functional ICP0 but this does not lead to virus production
(Thompson & Sawtell, 2006).
This brief summary of the phenotype of ICP0-null mutant
HSV-1 illustrates the importance of ICP0 in both lytic and
latent infection. The biochemical mechanisms that contri-
bute to these phenotypes have been studied extensively.
Fundamentally, the core activity of ICP0 resides in its E3
ubiquitin ligase function associated with its RING finger
domain, because the absence of this activity renders the virus
as defective as an ICP0-null mutant. Nonetheless, ICP0 has
several other important motifs that are involved in substrate
targeting of its E3 ligase activity, or in other functions (Figs 1c
and 2). As a result, ICP0 has been implicated in the regulation
of protein stability, chromatin modification, interferon-
related pathways, the DNA damage response and a number
of other diverse cellular pathways. The following sections will
discuss advances in each of these aspects, but first it is
necessary to consider an underlying theme in ICP0 biology,
namely intrinsic resistance to virus infection.
(c)
(d)
USP7 ND10 Loc.RING nlsFHA SIAH
1 775
S224
T226
T231/T232
S365
S367
S371
S508
S514
S517/T518
116 156
Phos-1 Phos-2 Phos-3
618 634
T67
S64
FHA Phos
719401410
PML-I
1 532 EICP0 (EHV-1)
1 676 BICP0 (BHV-1)
1 410 PICP0 (PRV)
1 467 VICP0 (VZV)
1 775 ICP0 (HSV-1)
1 824 ICP0 (HSV-2)
RING
(a)
(b)
HSV-1 ICP0 (113) GDVCAVCTDEIAPHLRCDTFPCMHRFCIPCMKTWMQLRNTCPLCNAKLVYLIVGV (167)
HSV-2 ICP0 (122) GDVCAVCTDEIAPPLRCQSFPCLHPFCIPCMKTWIPLRNTCPLCNTPVAYLIVGV (176)
PRV  PICP0  (43) VMDCPICLDVAATEAQ--TLPCMHKFCLDCIQRWTLTSTACPLCNARVTSILHHV (95)
VZV  VICP0  (16) DNTCTICMSTVSDLGK--TMPCLHDFCFVCIRAWTSTSVQCPLCRCPVQSILHKI (68)
EHV  EICP0   (5) AERCPICLEDPSNYSM--ALPCLHAFCYVCITRWIRQNPTCPLCKVPVESVVHTI (57)
BHV  BICP0  (10) LGSCCICLDAITGAAR--ALPCLHAFCLACIRRWLEGRPTCPLCKAPVQSLIHSV (62)
Consensus           C IC D IA       LPCLH FC  CI RW     TCPLCN PV SLIH V
Zn2+ Zn2+
loop-1 loop-2α-helixβ -sheet β -sheet β -sheet
Fig. 1. Comparison of ICP0 and a number of its viral orthologues. (a) A representation of ICP0 and its orthologues encoded by
HSV-1, HSV-2, BHV-1 (BICP0), EHV-1 (EICP0), PRV (PICP0) and VZV (VICP0, also known as orf61p), indicating the relative
lengths of the polypeptides and the positions of their RING domains (black boxes). (b) Histogram depicting a consensus
sequence from the amino acid alignment of the a-herpesvirus ICP0 orthologue proteins described above (x-axis) against
conserved amino acid identity (absolute complexity; y-axis). The location of the RING domain in the consensus sequence is
highlighted (dashed line). (c) A map of the ICP0 primary sequence, highlighting regions of interest including the RING finger
domain (black box), known protein interaction motifs (grey boxes) and localization sequences (white boxes): FHA (fork head-
associated phosphorylation motif), SIAH (Seven in absentia homologue-binding motif), nls (nuclear localization sequence),
USP7 (ubiquitin-specific protease 7-binding motif), ND10 Loc. (region required for ND10 localization). Numbers refer to amino
acid coordinates within the ICP0 polypeptide sequence. Serine (S) and Threonine (T) residues that are known to be
phosphorylated are indicated. (d) Amino acid alignment of the RING finger domains of ICP0 and a number of its viral
orthologues, as described above. Grey bars highlight zinc (Zn2+) coordinating residues within the RING domains. Residues
that contribute to secondary structure or loop regions within the RING domain are highlighted by dashed lines.
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The concept of intrinsic antiviral resistance
The concept of intrinsic antiviral resistance is highly relevant
for an understanding of the ICP0 family of proteins. Also
known as intrinsic antiviral defence or intrinsic immunity,
this aspect of antiviral defence was first developed from the
phenomenon of retroviral restriction (Bieniasz, 2004). In
contrast to interferons and other cytokines in the innate
immune system, which induce the expression of cellular
proteins that impede virus infection (Goodbourn et al.,
2000), intrinsic resistance is mediated by constitutively
expressed cellular proteins that act within individual cells.
General characteristics of intrinsic resistance include cell or
species specificity, the potential to be overcome by high
amounts of infecting virus (i.e. the system can be saturated),
diversity in mode of action and stage of virus replication
targeted and in many cases counteracting viral regulatory
proteins. Thus, the outcome of infection can be determined
by the balance between the activities of intrinsic resistance
factors and the viral proteins that inactivate their effects.
This broad definition is clearly consistent with the
phenotype of ICP0-null mutant HSV-1.
The role of ND10 in intrinsic resistance
There is increasing evidence that the small nuclear
substructures known as ND10 or PML nuclear bodies are
involved in intrinsic resistance to herpesvirus infections
(Everett & Chelbi-Alix, 2007; Geoffroy & Chelbi-Alix, 2011;
Tavalai & Stamminger, 2008). The ND10 components that
have been most studied in terms of intrinsic resistance are
PML itself, Sp100, hDaxx and ATRX. Interest in the
connections between ND10 and herpesvirus infections
initially arose because of the observations that ICP0 first
localizes to then disrupts ND10, and because the genomes
of HSV-1 and several other DNA viruses become associated
with ND10 proteins (Everett, 2001; Everett & Chelbi-Alix,
2007; Maul, 1998). ICP0 also localizes to and disrupts
centromeres (see Table 1 for references) and at later times
of infection begins to accumulate in the cytoplasm (Lopez
et al., 2001), indicating its dynamic association with
cellular compartments during the course of infection.
The biochemical effects of ICP0 on PML and other ND10
components are summarized in a later section.
Table 1. Cellular proteins known to be targeted for proteasome-dependent degradation by ICP0 in a RING finger-dependent manner
during HSV-1 infection
Protein Localization/
pathway
Phenotype during HSV-1
infection
Methodology Reference(s)
PML isoform I.SUMO-
modified PML isoforms
I-VI. SUMO-modified
Sp100
Major ND10
constituent
proteins
Inhibition of intrinsic
antiviral immunity in
response to herpes virus
infection
Infection,
transfection,
inducible cell
line
Chelbi-Alix & de The´ (1999); Everett
et al. (1998a); Mu¨ller & Dejean
(1999); Parkinson & Everett (2000);
Gu & Roizman (2003); Everett et al.
(2010); Boutell et al. (2011);
Cuchet-Lourenc¸o et al. (2012)
High MW SUMO-1 and
SUMO-2/3 conjugated
proteins
Multiple To be determined Infection, inducible
cell line, in vitro
biochemistry
Everett et al. (1998a); Boutell et al.
(2011); Boyer-Guittaut et al. (2005)
DNA-PKcs DNA repair To be determined Infection Lees-Miller et al. (1996); Parkinson
et al. (1999)
RNF8, RNF168 DNA repair Inhibition of DNA repair.
Potential role in inhibiting
intrinsic antiviral immunity
Infection,
transfection, in
vitro biochemistry
Chaurushiya et al. (2012); Lilley et al.
(2010)
CENP-A, CENP-B,
CENP-C, CENP-I,
CENP-H, CENP-N
Centromere/
kinetechore
assembly
Cell cycle arrest in
pro-metaphase/interphase
centromere damage
response
Infection,
transfection,
inducible cell
lines
Everett et al. (1999a); Lomonte &
Everett (1999); Lomonte et al.
(2001); Lomonte & Morency (2007);
Morency et al. (2007); Gross et al.
(2012)
USP7, USP7b De-ubiquitinating
enzyme
Reciprocal activities: USP7
stabilization of ICP0, ICP0
degradation of USP7.
Infection, in vitro
biochemistry
Canning et al. (2004); Boutell et al.
(2005); Antrobus & Boutell, (2008)
IkBa NF-kB
transcriptional
activation
To be determined Transfection Diao et al. (2005)
IFI16 Nuclear innate
immune DNA
sensor
Inhibition of IRF-3
signalling
Infection Orzalli et al. (2012)
E2FBP1 Transcription Relief of viral transcriptional
repression
Transfection Fukuyo et al. (2011)
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Advances in the understanding of the role of ND10
components in intrinsic resistance have come from the use
of RNA interference (RNAi) technologies. ICP0-null mutant
HSV-1 replicates more efficiently in cells depleted of PML
(Everett et al., 2006), and PML is also involved in restriction of
infections by human cytomegalovirus (HCMV) (Tavalai
et al., 2006) and varicella zoster virus (VZV) (Kyratsous
& Silverstein, 2009). PML is a complex protein that is
expressed as several different isoforms (PML.I to PML.VI) that
have distinct properties. In one assay system, ectopic
expression of PML.I (the most abundant isoform) and
PML.II, but not the other isoforms, partially reversed the
effect of PML depletion on ICP0-null mutant HSV-1 infection
efficiency (Cuchet et al., 2011). In another example, PML.IV
was found to sequester progeny VZV capsids in nuclear ‘cages’
(Reichelt et al., 2011), and a later study made the important
finding that PML restricts VZV pathogenesis in the context of
human skin xenografts in the mouse (Wang et al., 2011).
Several studies have reported that Sp100, hDaxx and ATRX
also contribute to intrinsic resistance to various different
herpesviruses (Adler et al., 2011; Cantrell & Bresnahan, 2006;
Everett et al., 2008a; Full et al., 2012; Kim et al., 2011;
Lukashchuk et al., 2008; Lukashchuk & Everett, 2010; Preston
& Nicholl, 2006; Saffert & Kalejta, 2006; Tavalai et al., 2011;
Tavalai et al., 2008; Tsai et al., 2011; Woodhall et al., 2006).
The increase in ICP0-null mutant HSV-1 replication
efficiency in cells depleted individually of PML, Sp100,
hDaxx or ATRX are modest (5–10-fold) compared with the
full defect of the mutant virus. This might suggest that the
roles of ND10 components are relatively minor compared
with other means of host restriction, but it is also possible
that these factors act in a cooperative manner. Indeed,
depletion of PML and Sp100 simultaneously increases ICP0-
null mutant HSV-1 replication to a greater extent than
depletion of either protein alone (Everett et al., 2008a), and
simultaneous depletion of PML, Sp100 and hDaxx increases
ICP0-null mutant HSV-1 plaque formation by at least 50-
fold (Glass & Everett, 2013). Analogous results were found
in HCMV infection of cells depleted of both PML and
hDaxx (Tavalai et al., 2008). Therefore it appears that the
repressive effects of several ND10 components combine to
impart a significant component of intrinsic resistance to
HSV-1 replication. Also consistent with this hypothesis is
the observation that HCMV proteins IE1 and pp71, which
affect ND10 components PML/Sp100 and hDaxx/ATRX,
respectively, can substitute almost completely for ICP0 in its
core activities of stimulating lytic HSV-1 infection and de-
repression of quiescent viral genomes (Everett et al., 2013).
ICP0-mediated inhibition of the recruitment of
cellular repressors to HSV-1 genomes
One striking aspect of the behaviour of ND10 components
in response to HSV-1 infection is their recruitment to sites
that are closely associated with parental HSV-1 genomes
(Everett & Murray, 2005). When the association between
herpesvirus genomes and ND10 was first discovered, it was
debated whether this reflected a positive or negative
influence on viral infection (Maul, 1998). The evidence,
particularly the RNAi-mediated depletion work summar-
ized above, now indicates that it is a repressive cellular
response to the entry of the viral genome into the nucleus.
Recruitment of ND10 proteins to regions in close
proximity to the HSV-1 genomes occurs very rapidly
(Everett et al., 2007), but it is short lived and therefore hard
to detect during wt virus infection. In the absence of ICP0,
however, it is very prominent, particularly in cells at the
edges of developing plaques. ICP0 inhibits the recruitment
of several ND10 components, including PML, Sp100,
hDaxx, ATRX and the SUMO family of proteins (Cuchet-
Lourenc¸o et al., 2011; Everett & Murray, 2005; Lukashchuk
& Everett, 2010), and the ability of ICP0 to counteract this
recruitment correlates well with inactivation of intrinsic
resistance (Everett et al., 2009). The orthologues of ICP0
expressed by bovine herpesvirus type 1 (BHV-1), equine
herpesvirus type 1 (EHV-1) and pseudorabies (PRV) also
inhibit the recruitment of PML and hDaxx to the sites of
ICP0-null mutant HSV-1 genomes, in these cases without
major effects on the stability of PML (Everett et al., 2010).
These findings suggest that the recruitment reflects a
cellular response to viral infection that creates a repressive
environment to restrict viral gene expression. Interestingly,
repressed HSV-1 genomes in quiescently infected cultured
cells are sequestered within enlarged, spherical ND10-like
structures (Everett et al., 2007), and recent evidence has
found that analogous sequestration occurs in latently
infected mouse neurones (Catez et al., 2012).
Analysis of the features of PML, hDaxx and Sp100 that are
required for their recruitment to sites associated with HSV-1
genomes found that the SUMO-interaction motifs (SIMs) of
these proteins were in each case essential (Cuchet-Lourenc¸o
et al., 2011). PML.I can partially reverse the increase in ICP0-
null mutant HSV-1 plaque formation in cells depleted of
endogenous PML (Cuchet et al., 2011), whilst reconstitution
of hDaxx-depleted cells with wt hDaxx completely restores
full repression (Lukashchuk & Everett, 2010). SIM mutant
versions of these proteins fail not only to be recruited to the
viral genomes, but also to act as repressors (Cuchet-
Lourenc¸o et al., 2011; Lukashchuk & Everett, 2010). These
data provide a link between the recruitment of these proteins
to sites associated with HSV-1 genomes and their roles in
intrinsic resistance. Note that, unlike the assembly of ND10
in uninfected cells, the recruitment of Sp100, hDaxx and
ATRX to the virus-induced ND10-like foci is not dependent
on PML (Everett et al., 2006, 2007, 2008a). The fact that
PML, Sp100 and hDaxx are all independently recruited to
viral genomes could explain why depletion of any individual
one of these repressive proteins results in only a limited
improvement in ICP0-null mutant plaque formation – the
full effects of ND10-mediated repression appear to be
dependent on the cooperative effects of multiple factors.
Identification of the cellular factors that are required for
the initial nucleation of ND10 proteins at sites associated
with HSV-1 genomes remains an important issue. Multiple
C. Boutell and R. D. Everett
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SUMO family members are present in the recruited foci,
and in the case of SUMO-2/3 this recruitment is PML
independent (Cuchet- Lourenc¸o et al., 2011). Therefore,
nuclear entry of the HSV-1 genome might stimulate a
cascade of SUMO conjugation events that initiate forma-
tion of these foci through SUMO–SIM interactions. A
prediction of this hypothesis is that SUMO conjugation is
involved in the recruitment process and intrinsic resist-
ance. Indeed, depletion of Ubc9, the SUMO E2-conjug-
ating enzyme that is essential for SUMO modification,
results in inefficient PML recruitment and a marked
decrease in the effectiveness of intrinsic resistance to ICP0-
null mutant HSV-1 (Boutell et al., 2011). A plausible
mechanism by which ICP0 could inhibit ND10 component
recruitment is presented in a later section.
ICP0 and chromatin-related regulatory pathways
The mechanisms by which viral transcription is repressed in
the absence of ICP0 remain to be defined in detail. In recent
years there have been substantial advances in studies on the
role of chromatin structure in the regulation of HSV-1 and
HCMV gene expression during both lytic and latent infection
(reviewed by Knipe & Cliffe, 2008; Kutluay & Triezenberg,
2009b; Nevels et al., 2011). Because a number of viral
promoters in latent HSV-1 genomes are in a repressed
chromatin state that resembles facultative heterochromatin
(Cliffe et al., 2009) it is a reasonable hypothesis that ICP0
impedes the assembly of a repressed viral chromatin
structure. Indeed, it has been well established that the
presence of ICP0 correlates with active viral chromatin
configurations, and vice versa. What is less clear is whether or
not ICP0 influences chromatin structure directly through its
RING finger-dependent functions. The following sections
summarize the influence of ICP0 on viral chromatin
structure and the interplay between ICP0 and cellular
proteins involved in chromatin-mediated repression.
(i) ICP0 and viral chromatin structure
The HSV-1 genome is not nucleosome-associated prior to
its entry into the nucleus, and therefore any chromatin-based
regulation must depend on initial chromatin assembly. It is
generally accepted that HSV-1 genomes are only sparsely
associated with nucleosomes during lytic infection (reviewed
by Nevels et al., 2011), although there is evidence for the
presence of a higher density of ‘unstable’ nucleosomes on the
viral DNA (Lacasse & Schang, 2010, 2012). Chromatin
immunoprecipitation (ChIP) analysis indicated that total
histone H3 loading on HSV-1 promoter regions in human
embryo lung cells was reduced in the presence of high levels
of ICP0, with this reduction being more marked at 24 h
compared with 4 h post-infection (Ferenczy & DeLuca,
2009). There was also a higher proportion of H3 with an
active chromatin mark (acetylated on lysine residue 9) and a
lower proportion with a repressive mark (trimethylated on
lysine 9; H3K9me3) in the presence of ICP0 (Ferenczy &
DeLuca, 2009). Similar results were observed in HeLa cells,
although in this case an increased level of acetylated H3
associated with the viral genome was linked to the activities
of VP16 rather than ICP0 (Hancock et al., 2010).
ICP0 has the ability to induce de-repression of quiescent
HSV-1 genomes harboured in cultured cells (reviewed by
Efstathiou & Preston, 2005). There is a clear and important
distinction between events during the initial stages of lytic
infection (when nucleosome-free viral genomes might be
assembled into repressed or active chromatin structures)
and those during reactivation or de-repression, when a
presumably compact, repressed genome takes on a more open
chromatin configuration. One study found that ICP0-
mediated de-repression occurred concomitantly with a
reduction in H3K9me3 on viral promoters, although changes
in histone loading and/or acetylation did not always correlate
with the time-course or efficiency of viral gene expression in
the presence of ICP0 (Ferenczy & DeLuca, 2011). Another
study found little overall change in histone occupancy but a
substantial increase in levels of acetylated H3 during ICP0-
mediated de-repression (Coleman et al., 2008). On the other
hand, complementation of the expression defect of a VP16
activation domain mutant of HSV-1 by superinfection with
HSV-2 (thus providing both VP16 and ICP0) did not cause
reductions in histone loading or changes in their epigenetic
marks (Kutluay & Triezenberg, 2009a). All of these studies
concluded that ICP0-mediated reactivation does not neces-
sarily correlate with reduced overall histone loading, and it
appears that efficient ICP0-mediated reactivation can occur
without major effects on histone occupancy or acetylation
(Ferenczy & DeLuca, 2011). As yet, there is little mechanistic
information on how ICP0 might influence chromatin
occupancy, and it remains possible that its affects are indirect.
(ii) ICP0 and histone deacetylase enzymes
One hypothesis to explain how ICP0 might activate gene
expression is through inhibition of histone deacetylases
(HDACs) to maintain viral chromatin in an active config-
uration. Whilst attractive because of the analogies with well
understood cellular systems, there are several unresolved
issues. In the absence of ICP0, the great majority of the HSV-1
genome (including most IE promoters in the most restrictive
cell types) is very rapidly repressed. For HDACs to be a major
factor in this repression requires that viral chromatin
assembly be equally rapid. Whilst there is evidence for an
early association of histones with viral DNA (reviewed by
Nevels et al., 2011), the existing evidence suggests that histone
loading is light during the early stages of infection of cultured
cells, even when the viral genome is repressed. HDAC
inhibitors do not complement ICP0-null mutant viruses in
the most restrictive cell types, such as human diploid
fibroblasts (Everett et al., 2008a; Nicholl & Preston, 1996;
Terry-Allison et al., 2007), although they can stimulate ICP0-
null mutant HSV-1 gene expression and infection in some cell
types, particularly neurones (Arthur et al., 2001; Danaher
et al., 2005; Poon et al., 2006; Terry-Allison et al., 2007). On
the other hand, ICP0 can be co-immunoprecipitated from
Biological properties of ICP0
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cells expressing high levels of class II (but not class I) HDACs
(Lomonte et al., 2004). Analogous studies with other
alphaherpesviruses have reported interactions between ICP0
orthologues and HDACs, and/or stimulatory effects of HDAC
inhibitors on viral gene expression (Wang et al., 2009; Zhang
et al., 2006; Zhang & Jones, 2001). An important observation
was that, unlike HDAC inhibitors, ICP0 does not increase the
global levels of acetylated histone H4 (Lomonte et al., 2004).
Taking all these observations into account, it appears that the
hypothesis that the major pathway involved in ICP0 function
is through HDACs cannot be upheld in its simplest form, at
least in human diploid fibroblasts.
(iii) ICP0 and the CoREST/REST/HDAC1/LSD1
complex
Another mechanism by which ICP0 could influence viral
gene expression through chromatin-related mechanisms is
via interactions with chromatin modifying complexes. One
prominent strand of research concerns the transcriptionally
repressive REST/CoREST/HDAC1/LSD1 complex. This
issue has stimulated much debate, involving a complex
region of ICP0 that has been linked with several functions
(Fig. 2). Initially, it was noted that ICP0 residues 537–613
(that include a low complexity serine/alanine-rich region)
show similarity to the N-terminal part of CoREST. It was
observed that, during HSV-1 infection, CoREST could be
detected in ICP0 immune precipitates, and that at mid to
late times of infection HDAC1 was displaced from the
REST/CoREST/HDAC1 complex and CoREST was partly
redistributed to the cytoplasm (although this latter effect
occurred independently of ICP0) (Gu et al., 2005).
Subsequently, GST pull-down assays identified a different
region of ICP0 that could interact with CoREST in vitro.
Given that GST fusions with ICP0 residues 543–768, 543–
718 and 693–768 could bind to CoREST with similar
efficiencies (Gu & Roizman, 2007), it appears that ICP0
sequences that are sufficient for interaction with CoREST
lie between residues 693 and 718. Investigation of amino
acid substitution mutations, however, identified a double
mutation at residues 671 and 673 that reduced the
interaction with CoREST, and an HSV-1 mutant (R8507)
expressing this mutant form of ICP0 replicated less
efficiently than the wt virus (Gu & Roizman, 2009). On
the basis of these pieces of evidence, and the properties of
HSV-1 recombinants expressing fragments of CoREST (Du
et al., 2010; Gu & Roizman, 2007), it has been proposed
that the biological functions of ICP0 during lytic and latent
infection can be largely explained by its effects on the
REST/CoREST/HDAC1/LSD1 complex.
This hypothesis is complicated by the number of functions
attributed to overlapping segments of the relevant region of
ICP0, including a region proposed to have ubiquitin ligase
activity (HUL1; Hagglund & Roizman, 2002), sequences
required for binding to USP7 and localization to ND10, and
a set of sequences related to SIM (Fig. 2). The HUL1 activity
could not be independently confirmed (Boutell et al., 2002;
Vanni et al., 2012) and has not been further investigated.
Given this complexity, mutation of sequences implicated in
CoREST binding may also affect the efficiency of ICP0
localization to and effects on ND10. Indeed, mutant R8507
exhibits reduced rates of PML degradation (Gu & Roizman,
2009). A recent independent analysis of the ICP0 CoREST-
binding mutant R8507 found only a small defect in plaque -
forming efficiency, and the mutation did not reduce ICP0-
mediated de-repression of gene expression in quiescently
infected cells in terms of the proportion of reactivated
genomes (although the total level of reactivated gene
expression was less than that induced by the wt virus)
(Ferenczy et al., 2011). Depletion of CoREST using stable
RNAi neither improved plaque forming efficiency of ICP0-
null mutant HSV-1 nor impacted on the replication
efficiency of the wt virus (Everett, 2010). In contrast, it has
been proposed that CoREST is required for efficient IE gene
expression, but inhibitory for transcription of early genes
(Zhou et al., 2011). Clarification of this discussion awaits
independent analysis from other groups but, given that
deletion of the whole CoREST-binding region impacts on
ICP0 activity to a far lesser degree than deletion of the RING
finger (Everett et al., 2009; Ferenczy et al., 2011), at present it
appears that CoREST does not play a dominant role in
regulating the onset of lytic HSV-1 infection or de-
repression of quiescent viral genomes in cultured cells.
(iv) ICP0 and the hDaxx/ATRX chromatin modification/
histone chaperone complex
The cellular proteins ATRX and hDaxx form another
chromatin modifying complex that is influenced by ICP0
and several other herpesvirus regulatory proteins (Cantrell
M1                   R8507
USP7 binding    ND10 localization
SLS5 SLS6 SLS7
500                                 600                                    700                         775
HUL1
Minimal CoREST binding
NLS                 Ser/Ala-rich
620                  671/673
Fig. 2. A detailed map of the C-terminal third of ICP0. A
representation of the C-terminal 275 amino acids of ICP0,
showing the nuclear localization signal (NLS), a low complexity
serine/alanine-rich region with similarity to the N-terminal region of
CoREST, the position of a point mutation that inactivates binding
to USP7 (M1), a region reported to impart ubiquitin ligase activity
distinct from that of the RING finger (HUL1), the maximum extents
of the regions required for USP7 binding and ND10 localization,
the implied minimal region required for interaction with CoREST,
the C-terminal three SIM-like sequences (SLS5, -6 and -7), and
the positions of mutations in mutant R8507 that decrease binding
to CoREST in immunoprecipitation assays.
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& Bresnahan, 2006; Lukashchuk et al., 2008; Lukashchuk &
Everett, 2010; Preston & Nicholl, 2006; Saffert & Kalejta,
2006; Tsai et al., 2011; Woodhall et al., 2006). This complex
not only interacts with HDACs and histones (Hollenbach
et al., 2002; Xue et al., 2003), it also has histone chaperone
activity (Drane´ et al., 2010; Lewis et al., 2010). There are
strong indications, therefore, that these proteins could
influence HSV-1 chromatin assembly or structure, which
might explain their roles in intrinsic resistance and
repression of viral transcription (see above). Consistent
with this hypothesis, ATRX mRNA and protein stability are
downregulated during HSV-1 infection through the
combined activities of the viral microRNA miR-H1, the
RNase activity of vhs, and the ubiquitin ligase activity of
ICP0 (Jurak et al., 2012). Furthermore, exogenous
expression of ICP0 displaces ATRX and hDaxx from an
integrated and transcriptional repressed HCMV promoter-
driven transgene array (Newhart et al., 2012). These data
suggest that ICP0, either directly or indirectly, influences at
least two cellular proteins implicated in heterochromatin
assembly.
The E3 ubiquitin ligase activity of ICP0
The most prominent motif that ICP0 shares with its
orthologues is an N-terminal C3HC4 RING finger domain
(Fig. 1; Barlow et al., 1994; Everett et al., 1993, 2010). This
domain confers E3 ubiquitin ligase activity (Boutell et al.,
2002; Diao et al., 2005; Everett, 2000; Everett et al., 2010;
Grant et al., 2012; Hagglund et al., 2002; Parkinson &
Everett, 2001; Vanni et al., 2012; Walters et al., 2010) and is
required for ICP0 to mediate the ubiquitination and
proteasome-dependent degradation of a diverse range of
cellular proteins (Table 1). Viruses that express ICP0
mutants with defective RING finger regions have replica-
tion defects equivalent to that of ICP0-null mutant HSV-1
(Everett, 1989; Everett et al., 2004; Lium & Silverstein,
1997) and fail to de-repress quiescent HSV-1 in cell culture
(Everett et al., 2009; Ferenczy et al., 2011; Harris et al.,
1989). The RING finger domain therefore plays a
fundamental role in the overall biology of ICP0 during
HSV-1 infection.
Whilst a detailed description of the ubiquitin-proteasome
pathway is beyond the scope of this article (for a review,
see Deshaies & Joazeiro, 2009), an understanding of the
biochemical activity of ICP0 requires knowledge of the basic
features of this pathway. E3 ubiquitin ligases provide the
substrate specificity for the transfer of ubiquitin from E2
ubiquitin-conjugating enzymes onto target substrate pro-
teins. This involves the formation of an isopeptide bond
between the C-terminal glycine residue of ubiquitin to the
side chain amino group of a lysine residue within the target
protein. This initial modification (termed mono-ubiquitin-
ation) can, in itself, alter protein function and is often
associated with intra-cellular signalling. Subsequent rounds
of ubiquitin transfer onto lysine residues in the anchored
ubiquitin molecule results in the formation of a poly-ubiquitin
chain. As ubiquitin contains seven lysine residues, each of
which can serve as an acceptor site for ubiquitin modification,
a large number of structurally diverse chain types can be
formed that differentially regulate many aspects of cell biology,
including the cell cycle (Lys-11 linked chains), proteasome-
dependent degradation (Lys-48 linked chains), as well as DNA
repair and innate immunity (Lys-63 linked chains; reviewed by
Trempe, 2011). Both substrate modification and poly-
ubiquitin chain formation are mediated through multiple E3
ligase protein–protein interactions. These interactions are
often transient due to the biochemical nature of substrate
ubiquitination and chain elongation.
The biochemical specificity of ICP0
Like many RING finger ubiquitin ligases, ICP0 stimulates
the formation of poly-ubiquitin chains and mediates the
ubiquitination of substrates in a RING finger-dependent
manner, both in vitro and in vivo (Boutell et al., 2002, 2005;
Lilley et al., 2010; Vanni et al., 2012) (Table 1). In vitro
assays provide model systems to test whether proteins that
are degraded during infection are direct substrates of ICP0,
as opposed to indirect phenotypes observed as a con-
sequence of ICP0 activity on other proteins or pathways.
Whilst in vitro studies can provide insight into the
biochemical specificity of ICP0, these assays have limita-
tions and require the careful use of controls and rate
limiting amounts of enzymes in order to generate reliable
results.
ICP0 stimulates the formation of unanchored poly-ubiquitin
chains in vitro in the presence of two highly homologous E2
ubiquitin-conjugating enzymes, namely UBE2D1 (UbcH5a)
and UBE2E1 (UbcH6) (Boutell et al., 2002; Vanni et al.,
2012). Both of these E2s are recruited to intranuclear foci by
ICP0 in a RING finger-dependent manner, demonstrating
RING-dependent E2 cellular sequestration (Boutell et al.,
2002). Exogenous expression of a catalytically inactive
mutant of UBE2D1, but not UBE2E1, inhibits degradation
of PML by ICP0 (Gu & Roizman, 2003). Therefore, the
ICP0–UBE2D1 interaction is important for the biological
role of ICP0 during infection, consistent with the observation
that RNAi depletion of UBE2D1 enhances PML stability
during wt HSV-1 infection (S. J. Griffiths and others,
unpublished data). ICP0 may utilize more than one E2
enzyme during infection, as there are examples of other
RING finger ubiquitin ligases that interact with multiple E2s
(Markson et al., 2009; van Wijk et al., 2009). Analogous to
other RING finger ubiquitin ligases (Deshaies & Joazeiro,
2009), ICP0 interacts with UBE2D1 via specific contact
residues within the a-helix and loop regions of the RING
domain (Vanni et al., 2012). Mutation of these residues not
only inhibits its ubiquitin ligase activity in vitro, but also
significantly impairs complementation of ICP0-null mutant
HSV-1 and de-repression of quiescent HSV-1 in cultured
cells (Vanni et al., 2012). These data are consistent with the
inhibitory effects of proteasome inhibitors on ICP0-depend-
ent stimulation of HSV-1 replication and reactivation
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(Everett et al., 1998b). Consequently, small molecule
inhibitors that block the ICP0–UBE2D1 interaction could
make effective therapeutic antiviral agents.
Mechanisms of substrate targeting by ICP0
One of the most significant challenges in ubiquitin research is
the identification of substrates that are specifically targeted by
individual E3 ubiquitin ligases. Whilst advances in proteomic
technologies have been very informative, they have also
highlighted the complexity of genuine substrate identifica-
tion (Bustos et al., 2012). For example, tandem affinity
purification tagged ICP0 isolated from transfected 293T cells
detected over 150 cellular interaction partners of ICP0,
relatively few of which were identified as being degraded
during HSV-1 infection (M. Chaurushiya and M. Weitzman,
personal communication). ICP0 is therefore likely to interact
with a number of proteins that form macro-molecular
complexes and/or have large protein interaction networks.
Some of these direct interactions may influence ICP0’s
activity or substrate specificity, whilst others may be indirect
binding partners that have no functional consequence on
HSV-1 infection. It is becoming increasingly clear, however,
that ICP0 can utilize multiple mechanisms, both direct and
indirect, in order to target functionally relevant substrates for
degradation (Fig. 3). The concepts discussed below are not
necessarily mutually exclusive.
(i) Direct substrate targeting
The simplest model of substrate targeting involves direct
protein–protein interaction between ligase and substrate
through specific recognition motifs (Fig. 3a). Whilst this
model is compelling, there are few documented examples
of this mechanism, the clearest being that of ubiquitin-
specific protease USP7. Like many ubiquitin ligases, ICP0
induces its own ubiquitination that decreases its stability
(Boutell et al., 2002; Canning et al., 2004). ICP0 counter-
acts this activity by interacting with USP7 (Everett et al.,
1999b), which in turn cleaves the ubiquitin moieties from
ICP0. The consequent increase in stability of ICP0 is the
most significant aspect of the ICP0–USP7 interaction,
indicating a positive role for USP7 in HSV-1 infection
(Canning et al., 2004). However, ICP0 has a reciprocal
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effect on USP7, resulting in USP7 ubiquitination and
degradation in a manner dependent on the USP7
interaction motif within ICP0 (Boutell et al., 2005). The
significance of this potential regulatory feedback loop
remains to be fully elucidated, but the stabilization of ICP0
by USP7 is likely to be important when relatively low levels
of ICP0 are expressed, for example during the initial stages
of reactivation from latency. A second example of a direct
substrate interaction involves PML.I (see SUMO-inde-
pendent targeting section below).
(ii) Phospho-specific substrate targeting
Direct substrate interactions through simple binding
motifs are unlikely to account for the diversity of identified
ICP0 substrates. Phosphorylation plays a role in regulating
ICP0’s ubiquitin ligase activity and substrate targeting
(Boutell et al., 2008; Chaurushiya et al., 2012). An elegant
example of ICP0 phospho-specific targeting (Fig. 3b)
involves RNF8, a cellular RING-finger ubiquitin ligase
implicated in DNA repair (Chaurushiya et al., 2012; Lilley
et al., 2010). RNF8 contains an FHA (forkhead associated)
domain that binds to a specific consensus motif within a
number of DNA repair proteins that are phosphorylated in
response to DNA damage (Mohammad & Yaffe, 2009). ICP0
mimics a cellular FHA phospho-binding site (67-pTELF-70;
Fig. 1c). Phosphorylation of ICP0 residue threonine 67 by
casein kinase I enables an interaction with RNF8, leading to
RNF8 ubiquitination and degradation (Chaurushiya et al.,
2012). Surprisingly, phosphorylation of this short motif also
enables ICP0 to interact with a large number of other cellular
proteins, including two other FHA domain containing
proteins, Chk2 and Nbs1 (Chaurushiya et al., 2012). Whilst
the significance of these additional interactions remains to be
investigated, phospho-specific targeting provides a potential
means by which ICP0 could influence the stability of
multiple cellular proteins and/or pathways in a controlled
manner.
Two other phosphorylation regions within ICP0, namely
Phos-1 and Phos-2 (Davido et al., 2005), also influence
ICP0’s ubiquitin ligase activity, including its ability to
stimulate the formation of co-localizing conjugated ubiqui-
tin (Phos-1) and the degradation of PML (Phos-2) in certain
cell types (Boutell et al., 2008). Mutation of these domains
also restricts HSV-1 pathogenesis and reactivation in an
animal model (Mostafa et al., 2011). It is likely therefore that
both viral and cellular kinases influence ICP0s ubiquitin
ligase activity during lytic infection and/or viral reactivation.
It is also possible that substrate phosphorylation affects ICP0
target specificity (Fig. 3c).
(iii) SUMO-dependent and -independent substrate
targeting
One of the best characterized substrates of ICP0 is PML
and its SUMO-modified forms (Chelbi-Alix & de The´, 1999;
Everett et al., 1998a; Mu¨ller & Dejean, 1999). However, only
recently have the molecular mechanisms involved come to
light (Boutell et al., 2011; Cuchet-Lourenc¸o et al., 2012).
ICP0 shares properties related to those of SUMO-targeted
ubiquitin ligases (STUbLs), a class of enzymes that contain
SIMs that mediate substrate interaction that is dependent on
the SUMO conjugation status of the target protein (Fig. 3d
and 3e; reviewed by Perry et al., 2008; Praefcke et al., 2012).
Like ubiquitination, SUMO modification regulates many
important cellular processes, including transcription, cel-
lular localization, DNA repair and the cell cycle. STUbLs
therefore have the potential to influence the activity of
multiple regulators within a given pathway in a synchro-
nised manner, without the need for independent protein
interaction motifs.
Two recent reports have identified several potential SIMs,
referred to here as SIM-like sequences (SLSs) within ICP0
(Boutell et al., 2011) and ORF61p (VICP0) (Wang et al.,
2011), as well as related SLSs within other ICP0 orthologue
proteins (Table 2). At least some of these sequences have
been implicated in interactions between SUMO family
members and ICP0 and ORF61p. For example, SLS4 of
ICP0 interacts with SUMO-2 (Boutell et al., 2011), and
because it lies immediately adjacent to the phosphorylated
region known as Phos-2 (Fig. 1c), it is possible that it is an
example of a phosphorylation regulated SIM (Stehmeier &
Muller, 2009). Mutation of multiple SLSs within ICP0
reduced its ability to induce the degradation of SUMO-
conjugated proteins in general, a phenotype shared by
other ICP0 family members (Boutell et al., 2011).
Simultaneous mutation of multiple SLSs also reduced
ICP0-mediated complementation and reactivation effi-
ciency, although mutation of individual motifs had little
or no effect (Boutell et al., 2011). This raises the possibility
of functional redundancy amongst the multiple SLSs
within ICP0 or its orthologues. Similarly, mutation of
SLSs within ORF61p reduced VZV replication in a human
skin xenograft mouse model system, although no signific-
ant defect in replication was observed in cell culture (Wang
et al., 2011). Collectively, these data suggest that SUMO-
binding and SUMO-dependent substrate-targeting may
be a conserved and biologically significant property of
this family of viral ubiquitin ligases (Fig. 3d and 3e).
This conclusion is consistent with the observation that
ICP0 orthologue proteins can partially substitute for the
functional activities of ICP0, despite not being able to
recapitulate all of ICP0’s effects on ND10 individual
constituent proteins (Everett et al., 2010).
At first glance these STUbL-like properties appear analogous
to the activities of the mammalian STUbL RNF4, which has
been shown to target SUMO-modified PML for degradation
following arsenic oxide treatment in a SIM- and RING
finger-dependent manner (Geoffroy et al., 2010; Lallemand-
Breitenbach et al., 2008; Tatham et al., 2008; Weisshaar
et al., 2008). There are, however, a number of important
distinctions (Boutell et al., 2011). All nuclear PML isoforms
contain the conserved RBCC (RING, B-box and coiled-coil)
tripartite motif and SUMO modification sites encoded
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within exons 1–6, followed by isoform-specific sequences
encoded by downstream exons (Jensen et al., 2001). ICP0
induces the degradation of all SUMO-modified species of
PML in an isoform-independent manner, consistent with its
STUbL-like activities. In contrast to RNF4, however, ICP0
also degrades PML.I, the most abundant of the PML
isoforms, regardless of its SUMO modification status
(Boutell et al., 2011; Cuchet-Lourenc¸o et al., 2012). This
activity is enabled by a direct and SUMO-independent
interaction with PML.I via isoform-specific sequences
encoded by exon 9 (Cuchet-Lourenc¸o et al., 2012). ICP0
therefore has two distinct mechanisms of targeting PML for
degradation – SUMO-dependent targeting of all SUMO-
modified PML isoforms and SUMO-independent targeting
of unmodified PML.I.
It is unclear why ICP0 has evolved two mechanisms for
targeting PML.I. One hypothesis involves the potential
distinction between direct substrate targeting and the
cellular localization of ICP0. Deletion of the C-terminal
third of ICP0, which includes three SLSs, reduces its
localization to ND10 (Cuchet-Lourenc¸o et al., 2012; Maul
& Everett, 1994; Meredith et al., 1995). The ability of ICP0 to
bind to multiple SUMO-modified proteins may therefore
increase its localization to the SUMO-rich ND10 envir-
onment, thereby enhancing sequence-specific recognition of
target proteins (such as PML.I) within these structures.
Alternatively, ICP0 may have evolved dual targeting
approaches in order to increase the diversity of its substrates
or the efficiency with which they are ubiquitinated. This may
be particularly important when ICP0 is in low abundance
during the earliest stages of lytic infection or viral
reactivation from latency.
(iv) Indirect substrate targeting
In this model, ICP0 might interact specifically with one
protein in order to target a partner of that protein (or
complex of proteins) for ubiquitination (Fig. 3f). Whilst this
model is attractive, there is as yet little biochemical evidence
to support it. However, ICP0 has been reported to interact
with at least three other cellular RING finger ubiquitin
ligases, namely RNF8, RNF168 and SIAH-1 (Chaurushiya
et al., 2012; Lilley et al., 2010; Nagel et al., 2011). These
interactions could expand the repertoire of ICP0s cellular
substrates and/or mechanisms of substrate targeting.
ICP0 and the DNA damage response
An exciting development in ICP0 research concerns its
effects on the recruitment of DNA damage response (DDR)
Table 2. Sequences of SLSs within ICP0 and its orthologues BHV-1, EHV-1, PRV and VZV
Numbers refer to the coordinates of the first residue shown of each SLS with respect to their individual ORF protein sequence. The hydrophobic
core of each SLS is shaded grey, with bold lettering denoting hydrophobic residues that conform to the SIM consensus as described in Hecker et al.
(2006); Song et al. (2004, 2005). Asterisks denote motifs that have been reported to bind SUMO (Boutell et al., 2011; Wang et al., 2011). Triplets of
serine or acidic residues adjacent to SLS sequences are underlined.
SLS #  ICP0 (HSV-1)  BICP0 (BHV-1)  VICP0/pORF61 (VZV)  
SLS -1  162.Y LIV GVTPS  173. LPLL PNT  93.DS IDIL PGD  
SLS -2  174.ST IPIV ND  253. LL FVAA  101.GD VI DLL PPS  
SLS -3  331.G VGVV EAEA  280. VV FLDT SDS  313. LFLL D 
SLS -4  360.DP IVI SDS P* 489. VI DLT 335.TA IQLI T 
SLS -5  650.S VV ALSPY * 404.LT IDLTSE SDS * 
SLS -6  665.DC LPIL DMET  
SLS -7  679.AY VVLV DQT   
SLS #  EICP0 (EHV-1)  PICP0 (PRV)   
SLS -1  308.E II DLTL DSD  181.DN IV EII QE   
SLS -2  355.SA ICLV SE  398.SAT IFIDLTQ DDD   
SLS -3  434. VAVVLV DR SSE    
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proteins to sites of damaged DNA. Such sites can be induced
by irradiation, and in this case they are termed irradiation
induced foci (IRIFs). DNA breaks are sensed by the MRN
complex, comprising Mre11, Rad50 and Nbs1, which then
recruits the ATM kinase, resulting in phosphorylation of
histone H2AX and its accumulation in chromatin surround-
ing the break. This is followed by recruitment of Mdc1,
53BP1, and other chromatin modification and repair
proteins. Recruitment of 53BP1, which serves as a convenient
marker for IRIFs, is dependent on two cellular RING finger
ubiquitin ligases, RNF8 and RNF168. HSV-1 activates and
interacts with the DNA damage response (Lilley et al., 2005;
Mohni et al., 2011; Weller, 2010; Wilkinson & Weller, 2005,
2006), but the formation of IRIFs in HSV-1-infected cells is
inhibited by ICP0 because it induces the degradation of both
RNF8 and RNF168 (Lilley et al., 2010). ICP0-null mutant
HSV-1 replicates more efficiently in cells lacking RNF8 and
RNF168, implying that they are involved in a repressive
response to HSV-1 DNA (Lilley et al., 2010, 2011).
Furthermore, IRIF-like foci assemble in regions adjacent to
HSV-1 genomes during the early stages of ICP0-null
mutant, but not wt, HSV-1 infection (Lilley et al., 2011).
H2AX and Mdc1 were shown to accumulate at these foci in
the presence of ICP0, but proteins downstream of RNF8/
RNF168 did not (Lilley et al., 2011). The recruitment of
DDR and ND10 proteins to regions close to the viral
genomes are analogous in some respects, particularly with
respect to the inhibitory effects of ICP0, but the former is
not dependent on PML or other ND10 proteins, and the
IRIF-like foci are spatially distinct from the corresponding
ND10-like foci (Lilley et al., 2011).
Other aspects of ICP0
This section discusses briefly some other recent develop-
ments in the ICP0 field not considered above.
Interaction with the cellular E3 ubiquitin ligase SIAH-1
SIAH-1 is a cellular ubiquitin ligase that has many identified
potential substrates, one of which is PML. A copy of a SIAH-
1-binding motif (PXAXVXPXXR) occurs at residues 401–
410 of ICP0 (Nagel et al., 2011). SIAH-1 co-immunopreci-
pitates with ICP0 and also co-localizes with ICP0 in infected
cells. Deletion of the interaction region reduced the ability of
plasmid expressed ICP0 to stimulate plaque formation of co-
transfected ICP0-null mutant viral DNA (Nagel et al., 2011).
This study raises the interesting possibility of viral and
cellular E3 ubiquitin ligases acting in concert to regulate each
other and their biological functions.
Interaction with transcription factor E2FBP1
Transcription factor E2FBP1 (ARID3a) enhances E2F1-
mediated transcriptional activation, and also disperses
ND10 by promoting the loss of SUMO-modified PML
(Fukuyo et al., 2004). ICP0 and E2FBP1 interact when
highly expressed in transfected cells, and E2FBP1 can be
ubiquitinated by ICP0 in a RING finger-dependent manner
(Fukuyo et al., 2011). High level expression of E2FBP1
caused decreased levels of ICP0 expression during HSV-1
infection, and therefore it was proposed that E2FBP1 has
restrictive effects on viral replication that are countered by
ICP0 (Fukuyo et al., 2011).
ICP0 in the tegument
Ever since ICP0 was identified as a component of the HSV-
1 tegument (Yao & Courtney, 1992), there has been an
intriguing question whether delivery of ICP0 into the cell
via the particle itself could have a biological impact.
Packaging of ICP0 requires its RING finger region and is
dependent on VP22 (Delboy et al., 2010; Elliott et al., 2005;
Maringer & Elliott, 2010; Potel & Elliott, 2005). A recent
proposal is that virion-associated ICP0 is required for
efficient delivery of the viral capsid to the nuclear periphery
(Delboy & Nicola, 2011). Unequivocal confirmation of a
role for virion ICP0 requires an experimental system in
which normal levels of ICP0 can be incorporated into
genotypically ICP0-null mutant virus particles. This is a
technically challenging but worthwhile objective.
ICP0 and inhibition of innate immunity signalling
pathways
ICP0-null mutant HSV-1 is sensitive to interferon (IFN)
pre-treatment in cultured cells and is highly inhibited by the
IFN system in vivo. ICP0 impedes IRF-3 signalling in some
experimental systems, thereby counteracting the induction
of IFN-stimulated gene expression that occurs in cells
infected with ICP0-null mutant or replication defective
HSV-1 mutants (reviewed by Sobol & Mossman, 2011). The
ICP0 orthologues expressed by VZV and BHV-1 have also
been shown to inhibit IRF-3-dependent signalling by
inducing the degradation of IRF-3 and STAT-1 (Saira
et al., 2007; Zhu et al., 2011). Depletion of STAT-1 or IRF-3
does not, however, increase the replication efficiency of an
ICP0-null mutant HSV-1 in human fibroblasts (Everett
et al., 2008b). Consequently, IRF-3 or STAT-1-dependent
signalling is unlikely to contribute to the replication defect
observed by an ICP0-null mutant HSV-1 in cell culture
(Everett et al., 2008b). Furthermore, ICP0 expressed in an
inducible cell line system is unable to counteract STAT-1- or
IRF-3-dependent signalling pathways (Everett & Orr, 2009).
A plausible explanation for the apparent conflict between
these studies is that ICP0 may be unable to block IRF-3-
dependent signalling when restricted to the nucleus
(Paladino et al., 2010). However, a recent study made the
intriguing observation that ICP0 induces the degradation of
the nuclear DNA sensor IFI16, a protein implicated in IRF-3
activation following viral DNA entry into the nucleus
(Orzalli et al., 2012). This exciting result promises further
developments in the understanding of the interplay between
ICP0 and innate immunity pathways.
ICP0 and VICP0 have also been linked to regulation of the
NF-kB pathway, albeit in different ways. ICP0 impedes NF-kB
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signalling by promoting the degradation of the Toll-like
receptor TLR2 (van Lint et al., 2010), and it also blocks
the TLR pathway and NF-kB activation by a variety of
stimuli (Daubeuf et al., 2009). VICP0 impedes NF-kB
signalling in dendritic cells in a RING finger-dependent
manner at a stage downstream of IkBa phosphorylation but
upstream of nuclear import of the NF-kB subunits p50 and
p65 (Sloan et al., 2012). Taken together, these studies
indicate that in addition to its nuclear functions, ICP0
family members also have cytoplasmic functions that
impede cellular responses to virus infection. Whilst there
is mounting evidence implicating a role for ICP0 in the
inhibition of innate immunity signalling, further studies are
required in order to determine whether these proteins are
directly targeted for ubiquitination by ICP0.
Concluding remarks
Studies over the past three decades have shown that ICP0
directly influences, and in some cases inhibits, many
fundamental cellular processes, including DNA repair,
transcription, the cell cycle, and innate and intrinsic antiviral
immunity. Recent work has begun to define the biochemical
mechanisms by which these functions are achieved. As the
number of pathways known to be influenced by ICP0 grows,
it has become increasingly important to understand their
relative contributions to the regulation of lytic infection and
viral reactivation.
ICP0 uses multiple mechanisms to target a broad range of
cellular substrates for degradation. Due to the variety of
mechanisms employed, it is plausible that some of the cellular
proteins degraded by ICP0 have little or no functional
influence on the outcome of HSV-1 infection. The challenge,
therefore, is to distinguish the substrates that are functionally
relevant to the biology of HSV-1 from those that are innocent
bystanders. This is particularly pertinent in light of the
STUbL-like activity of ICP0 that leads to the degradation of
numerous SUMO-modified proteins during infection. Whilst
there is clear evidence that certain SUMO-modified ND10
proteins contribute to the repression of ICP0-null mutant
replication, and that the SUMOmodification pathway plays a
role in mediating intrinsic immunity, it is likely that many of
the SUMO-modified proteins that are degraded have little
direct impact on the biology of HSV-1. It is of interest,
however, that several viruses, including avian adenovirus
(Boggio et al., 2004) and human papilloma virus (Heaton
et al., 2011), also express proteins that interfere with SUMO
modification. As SUMO conjugation regulates aspects of
innate and intrinsic immunity, and also transcription
(reviewed by Hay, 2005; Wimmer et al., 2012), one can
speculate that SUMO modification could influence the
antiviral activity of a number of cellular proteins. An
understanding of the biochemical activity and substrate
specificity of viral ubiquitin ligases like ICP0, or viral proteins
that co-opt cellular ubiquitin ligase complexes during
infection, may enable the development of novel avenues of
therapeutic intervention.
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